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Abstract 
BACKGROUND: Obesity is a multifactorial disease that is dangerous and is a factor in the emergence of serious 
diseases such as dyslipidemia, stroke, coronary heart disease and others. In Type 2 Diabetes Mellitus (T2DM) 
patients there is a disorder of lipid metabolism, namely dyslipidemia. Changes in lipid profile that occurred were 
an increase in total cholesterol levels, Low-Density Lipoprotein (LDL), and triglycerides, and decreased levels of 
high-density lipoprotein (HDL). The phenomenon of an increase in T2DM patients in Indonesia caused double 
mortality in recent decades. 
AIM: This study was to determine the relationship between obesity and lipid profile in T2DM patients at Pirngadi 
Medan Hospital in 2018. 
METHODS: This study was conducted in an observational analytic with a cross-sectional study approach. Fifteen 
obese patients with T2DM who were treated at the Endocrine and Metabolic Polyclinic in Pirngadi General 
Hospital Medan from January to December 2018 were recruited into the study sample. 
RESULT: Based on the analysis using the results of a one-way correlative analytical test showing that there was 
a positive correlation between obesity and total cholesterol levels (r = 0.209; p = 0.455) and LDL levels (r = 0.335; 
p = 0.222) but not significant. There was a negative correlation between obesity and HDL levels (r = -0.072; p = 
0.798) and triglyceride levels (r = -0.025; p = 0.930) but not significant. There was no significant relationship 
between obesity and blood glucose levels (r = 0.463; p = 0.082). This study concluded that there was no 
significant relationship between obese patients and lipid profiles in T2DM patients. 
CONCLUSION: Obesity positively correlates with blood glucose level, but its correlation with a lipid profile is not 
reliable. 
 
 
 
 
Introduction 
 
Diabetes Mellitus (DM) is a group of metabolic 
diseases characterised by hyperglycemia due to 
defects insulin work in the liver and peripheral tissues, 
insulin secretion from pancreatic beta cells, or both 
[1]. Nutritional status influences the incidence of Type 
2 DM (T2DM). High BMI (Body Mass Index) has a 2 
times greater risk of developing T2DM compared to 
low BMI. The results showed that general obesity had 
a risk of 2.24 times while abdominal obesity had a risk 
of 2.44 times for the occurrence of DM [2]. 
In T2DM patients, abnormalities of lipid 
metabolism can be found in the form of dyslipidemia. 
Dyslipidemia is a disorder of lipid metabolism 
characterised by an increase or decrease in lipid 
fraction in the plasma. The main lipid fraction 
abnormalities include increases in total cholesterol, 
triglycerides, Low-Density Lipoprotein (LDL), and 
decreased High-Density Lipoprotein (HDL). 
Dyslipidemia caused by DM is secondary dyslipidemia 
[3], [4]. 
Since 1980 the incidence of obesity in the 
epidemic has begun to increase. Where currently, 
more than 30% of the US population is obese with a 
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Body Mass Index (BMI) more than 30 kg/m² and 
almost two-thirds are overweight (BMI between 25 
and 29.9 kg/m²) [4], [5]. 
In Indonesia, the incidence of obesity 
continues to increase. Where in adult men there was 
an increase from 13.9% in 2007 to 19.7% in 2013? 
Whereas in adult women there was a very high 
increase reaching 18.1%, from 14.8% in 2007 to 
32.9% in 2013 [6]. 
Obesity is a risk factor for developing insulin 
resistance and type 2 diabetes. In 2015, an estimated 
2.3 billion adults will experience overweight, and 700 
million of them will be obese. Significant relationship 
exists between per cent body fat and body weight in 
DM, besides that the prevalence of diseases 
associated with insulin resistance increases together 
with increasing BMI because an increase in adipose 
tissue is characterised by decreased HDL and 
increased triglycerides [7]. 
Obesity is a multifactorial disease that rises 
very sharply throughout the world which reaches 
dangerous levels and is a factor for the emergence of 
serious diseases including hypertension, stroke, 
dyslipidemia, coronary heart disease, and type 2 
diabetes [8]. Based on the background described, the 
researchers were interested in examining the 
relationship between obesity and lipid profile in 
patients with type 2 diabetes. 
 
 
Material and Methods 
 
This study was conducted in an observational 
analytic study with a cross-sectional approach. In this 
study, no follow-up was carried out on the 
measurements taken. This study was conducted on a 
set of objects, within a certain period aimed at 
knowing the relationship of obesity and lipid profile in 
patients with type 2 diabetes mellitus. Fifteen obese 
patients with type 2 DM who were treated at the 
Endocrine and Metabolic Polyclinic in Pirngadi 
General Hospital Medan from January to December 
2018 were recruited to become a research sample. 
Inclusion criteria were m en and women who 
suffer from obesity (BMI > 25 kg/m² or obesity I and 
obesity II), adults over 25 years, and willing to give 
written permission after being given informed consent 
to take part in this research 
Exclusion criteria were patients who are not 
cooperative, patients suffering chronic diseases, the 
patient's health condition is not possible to take part in 
this study, Patients are outside the city so they cannot 
take part in the study according to the set schedule 
The variables examined in this study were the 
independent variable was Obesity (Obesity I and 
Obesity II). The dependent variables were lipid 
profiles (total cholesterol, HDL, LDL and triglycerides). 
In this study, the patient's lipid profile data 
were obtained from the report of the attached 
laboratory examination results and the method of 
measurement by looking at the lipid profile data from 
the laboratory examination in units of mg/dl. Obesity is 
measured by the measurement body Mass Index 
(BMI) (body weight kg/body height m
2
). 
 
Statistical analysis 
Data were analysed through statistical 
calculations to test hypotheses using the Pearson 
correlation test method. If the normality test was found 
that the data is not normally distributed, the 
hypothesis test could be done using the Spearman 
correlation test method. P value considered significant 
if it is less than 0.05 
 
 
Results 
 
The 15 diabetic patients who were divided 
into 4 men and 11 women in the Internal Medicine 
Department at the Endocrine and Metabolic Polyclinic 
in General Hospital Pirngadi Medan, the 
characteristics in Table 1. 
Table 1: Basic characteristics of research subjects 
Characteristics Mean ± SD 
Age (year)  56.733 ± 10.271 
Body weight (kg)* (Md, Min, Max)  
 
77.533 (75,65,106) 
Body height (cm)  
Cholesterol total 
HDL 
LDL 
Triglycerides 
IMT 
154.00 ± 7.156 
230.2 ± 45.896 
53.6 ± 13.69 
128.6 ± 38.52 
240.86 ± 219.10 
32.83 ± 3.05 
Blood Glucose 209.06 ± 84.11 
Systole 
Diastole 
138 ± 14.735 
86.66 ± 9.75 
Md: Median, Min: minimum, Max: maximum. 
 
Based on the results obtained from the 
correlative analytic test found a positive correlation 
between obesity and Total Cholesterol levels (r = 
0.209; p = 0.455) and LDL levels (r = 0.335; p = 
0.222) but not significant. There was a negative 
correlation between obesity and HDL levels (r = -
0.072; p = 0.798) and triglyceride levels (r = -0.025; p 
= 0.930) but not significant. There was no significant 
relationship between obesity and blood glucose levels 
(r = 0.463; p = 0.082), (Table 2). 
Table 2: The Correlation between obesity and lipid profiles 
Variable r value P value 
Cholesterol total 0.209 0.455 
HDL -0.072 0.798 
LDL 0.335 0.222 
Triglycerides -0.025 0.930 
Glucose 0.463 0.082 
P value considered significant if it is less than 0.05. 
Silitonga et al. Correlation between Obesity and Lipid Profile in Type 2 Diabetes Mellitus Patients 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Apr 30; 7(8):1309-1313.                                                                                                                                                   1311 
 
In Table 3 there was a positive relationship 
between obesity and systolic blood pressure (r = 
0.213) but not diastole (r = -0.226). 
Table 3: Correlation of obesity with blood pressure 
Group Obesity 
r value P value 
Sistole 0.213 0.446 
Diastole -0.226 0.418 
 
 
 
Discussion 
 
In this study, 15 samples were obtained that 
met the inclusion and exclusion criteria. The sample 
consisted of 4 men (10%) and 11 women (90%). This 
finding is by the opinion of Brunner and Suddart 
(2002) who stated that women suffer from diabetes 
mellitus more than men. This is triggered by the 
presence of a greater percentage of body fat in 
women compared to men which is one of the factors 
that can reduce sensitivity to the workings of insulin in 
the muscles and liver [9]. 
Fluctuations in estrogen levels can affect 
blood glucose levels. When estrogen levels increase, 
the body can become resistant to insulin [10]. Irawan 
(2010) stated that menopause causes body fat 
distribution to be easily accumulated due to these 
hormonal processes so that women are at risk of 
suffering from T2DM [11]. 
The average BMI of the patient is 32.83. The 
average total cholesterol level was 230.2 gr/dl, 53.6 
gr/dl HDL levels, 128.6 gr/dl LDL levels, average 
triglycerides 240.86 gr/dl and the average blood 
glucose level 209.06 mg/dl (Table 1). 
To find out the relationship between obesity 
and lipid profile in patients with type 2 diabetes, a one-
way correlative analytic test was performed. The 
correlative analytic test results between obesity and 
lipid profile (total cholesterol, HDL, LDL and 
triglyceride) and blood glucose in table 2. The results 
obtained showed a positive correlation between 
obesity levels and total cholesterol levels (r = 0.209; p 
= 0.455) and LDL (r = 0.335; p = 0.222). There was a 
positive relationship between the two but not 
significant. There was a negative correlation of HDL 
levels (r = -0.072; p = 0.798) and triglyceride levels (r 
= -0.025; p = 0.930) but not significant. With a p-value 
considered significant, it is less than 0.05. This is not 
by the theory that the most frequent picture of 
dyslipidemia in type 2 DM is a decrease in HDL levels 
and an increase in triglyceride levels by the theory 
[12]. 
In this study, there was a positive correlation 
between obesity and blood glucose levels (r = 0.463; 
p = 0.082). The results of this study are not much 
different from previous studies conducted by Jin Ook 
Chung, Dong Hyeok Cho, Dong Jin Chung, and Min 
Young Chung (2012) in the Associations among Body 
Mass Index, Insulin Resistance, and Pancreatic-Cell 
Function in Korean Patients with New-Onset Type 2 
Diabetes. This study showed that there was a 
significant relationship between BMI and the 
occurrence of insulin resistance which caused an 
increase in fasting blood glucose levels, p < 0.05 [13]. 
The results of other studies were also 
conducted by Ninh T. Nguyen, Xuan-Mai T Nguyen, 
John Lane, and Ping Wang (2011) in Relationship 
Between Obesity and Diabetes in US Adult 
Population: Findings from the National Health and 
Nutrition Examination Survey, 1999-2006 showed a 
significant relationship between obesity and the 
occurrence of type 2 diabetes mellitus [14]. The 
results of this study meant that the greater body mass 
index value, the greater the fasting blood glucose 
value. The greater body mass index value means the 
patient leads to obesity. This was accordance with the 
theory of Suyono (2011), that the risk factors of type 2 
diabetes mellitus are overweight/obesity factors which 
include lifestyle changes from traditional to the 
western lifestyle, overeating, and relaxed life (lack of 
motion) [15]. 
In the digestive system, food is broken down 
into the basic ingredients of the food itself. 
Carbohydrates become glucose, proteins become 
amino acids, and fats become fatty acids. The three 
food substances will be absorbed by the intestine and 
then enter the blood vessels and circulated throughout 
the body to be used by organs as fuel. To function as 
a fuel, food cells, especially glucose, must be 
metabolised first. In the metabolic process, insulin 
plays an important role, which is to enter glucose into 
cells, which can then be used as fuel [15], [16]. 
In normal circumstances, it means that insulin 
levels are enough and sensitive, insulin will be 
captured by insulin receptors that are on the cell 
surface, and then open the cell entrance, so that 
glucose can enter the cell and then burned into 
energy. As a result, blood glucose levels become 
normal [15]. This is different in the state of obesity, an 
increase in mRNA Lipopolysaccharides (LPS) -
induced TNF-α factor (LITAF) and protein levels along 
with increased BMI indicate a parallel relationship 
between LITAF and metabolic disorders. 
According to the study, LITAF is activated in 
obese patients and contributes to the development of 
obesity which induces inflammation and insulin 
resistance, since LITAF plays a role in the 
inflammatory process in regulating the expression of 
TNF-α, IL-6 and MCP-1 which results in insulin 
resistance, and TLR4. One of the LITAF receptors in 
macrophages can also be stimulated by free fatty 
acids which can cause an inflammatory process in 
obese patients. LITAF is a TNF-α description of the 
regulator that should play a role in the immune 
mechanism against infection. The LITAF gene is 
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located at 16p13.13 which is significantly present in 
lymph, lymph nodes, and peripheral blood leukocytes. 
TNF-α is a strong trigger for proinflammatory 
cytokines such as IL-6, MCP-1, leptin and PAI-1. It is 
very involved in the inflammatory process in obese 
patients. The increase in TNF-α observed in fat tissue 
in obese patients shows a direct relationship to the 
emergence of insulin resistance in obese patients 
[17]. The occurrence of insulin resistance causes 
glucose circulating in the blood to be unable to enter 
the cell, so the sugar level in the blood becomes 
higher than normal [15]. 
Hyperglycemia in people with diabetes 
mellitus is also closely related to fat metabolism. Fat 
has the main task of storing energy in the form of 
triglycerides through the process of lipogenesis which 
occurs in response to excess energy and mobilises 
energy through the process of lipolysis in response to 
energy shortages. Under normal circumstances, these 
two processes are strictly regulated [18]. 
The condition of obesity is caused by 
excessive intake of nutrients continuously causing fat 
deposits to become excessive. Deposits of fatty acids 
in the form of chemical compounds in the form of 
triacylglycerol contained in adiposity cells can protect 
the body from the toxic effects of fatty acids. Freeform 
fatty acids can circulate in blood vessels throughout 
the body and cause oxidative stress which we are 
familiar with lipo-toxicity. The emergence of lipo-
toxicity effects caused by several free fatty acids 
released by the triacylglycerol to compensate for the 
destruction of excessive fat deposits affects the 
adipose and non-adipose tissue and plays a role in 
the pathophysiology of diseases in various organs 
such as the liver and pancreas. This release of free 
fatty acids from excessive triacylglycerol can also 
inhibit fat synthesis and reduce the clearance of 
triacylglycerol. This can increase the tendency of 
hypertriglyceridemia. 
The release of free fatty acids by endothelial 
lipoprotein from triglycerides which increases in the 
increase of lipoprotein β causes lipo-toxicity which 
also interferes with the function of insulin receptors. 
The consequence of insulin resistance is 
hyperglycemia, which is compensated by glucose 
synthesis from the liver (gluconeogenesis), which 
contributes to aggravating hyperglycemia. 
Free fatty acids also contribute to 
hyperglycemia by reducing glucose use from insulin-
stimulated muscles. Lipotoxicity due to excess free 
fatty acids also decreases insulin secretion from 
pancreatic β cells, which ultimately β cells will 
experience fatigue [19]. The weakness of this study is 
a cross-sectional study that has limitations: 1. Not all 
confounding variables can be controlled properly so 
that better follow-up research is needed with 
appropriate research designs. 2. This study is based 
on local state hospitals so that to generalise to the 
population of type 2 diabetes mellitus with obesity 
globally should be wiser. 3. The number of samples is 
limited so that more samples are needed. Further 
research is needed with better research designs and 
with more and varied samples to prove the 
relationship between Obesity and lipid profiles in 
patients with type 2 DM. 
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